STERIS plc reported an 11% increase in revenue to $1.28 billion for the first quarter of fiscal 2024, with constant currency organic revenue also increasing by 11%. As reported diluted earnings per share increased to $1.25, and adjusted earnings increased to $2.00. The company has updated its fiscal 2024 outlook to reflect the acquisition of BD surgical instrumentation assets.
First quarter revenue growth of 11% as reported and constant currency organic.
As reported diluted earnings per share increased to $1.25; adjusted earnings increased to $2.00.
Fiscal 2024 outlook updated to reflect acquisition of BD surgical instrumentation assets.
Healthcare revenue grew 17% to $818.9 million, driven by improvements in capital equipment, consumable, and service revenue.
STERIS has updated its fiscal 2024 outlook to reflect the acquisition of BD surgical instrumentation assets. The company now expects as reported revenue to increase 9-10%, constant currency organic revenue growth is expected to be 6-7%, and adjusted earnings per diluted share are anticipated to be in the range of $8.60 to $8.80. Free cash flow for fiscal 2024 is now anticipated to be $685 million.
Visualization of income flow from segment revenue to net income